Wuyi International Pharmaceuticals

Sanai Health Industry Group, formerly known as Wuyi International Pharmaceuticals, is a Chinese pharmaceutical company specializing in the development, manufacturing, and marketing of Western and Traditional Chinese Medicines (TCM). The company is best known for its flagship product, the Perilla Oil Capsule, which is widely used in China for the treatment of hyperlipidemia. In addition to its core pharmaceutical operations, the group has expanded into finance leasing and general trading services. Although the company was delisted from the Hong Kong Stock Exchange in 2021 following a period of trading suspension, it remains an active business entity. It operates through key subsidiaries such as Fujian Sanai and Fuzhou Sanai, maintaining manufacturing facilities in Fuzhou and a corporate headquarters in Hong Kong.